Literature DB >> 32013556

A Retrospective Study of the Clinical Characteristics Associated with Alcohol and Cannabis use in Early Phase Psychosis.

Jacob Cookey1,2, Jacob McGavin3, Candice E Crocker1,2,4, Kara Matheson5, Sherry H Stewart1,6, Philip G Tibbo1,2.   

Abstract

OBJECTIVE: Alcohol and cannabis misuse are common in patients with early phase psychosis (EPP); however, research has tended to focus primarily on cannabis misuse and EPP outcomes, with a relative lack of data on alcohol misuse. This retrospective cross-sectional EPP study investigated the relationship between cannabis, alcohol, and cannabis combined with alcohol misuse, on age, gender, psychotic, depressive and anxiety symptom severity, and social/occupational functioning, at entry to service.
METHODS: Two-hundred and sixty-four EPP patients were divided into 4 groups based on substance use measured by the Alcohol, Smoking and Substance Involvement Screening Test: (1) no to low-level cannabis and alcohol misuse (LU), (2) moderate to high alcohol misuse only (AU), (3) moderate to high cannabis misuse only (CU), and (4) moderate to high alcohol and cannabis misuse (AU + CU).
RESULTS: We found significant between group differences in age (with the AU group being the oldest and AU + CU group the youngest) as well as gender (with the CU group having the highest percentage of men). There were also group differences in positive psychotic symptoms (lowest in AU group), trait anxiety (highest in AU + CU group), and social/occupational functioning (highest in AU group). Further regression analyses revealed a particularly strong relationship between AU + CU group and trait anxiety (3-fold increased odds of clinical trait anxiety for combined misuse of alcohol and cannabis compared to non/low users).
CONCLUSIONS: This study demonstrates the unique demographic and clinical characteristics found in the EPP population at entry to care associated with alcohol and cannabis misuse both separately and in combination. This work highlights the importance of including the assessment of alcohol misuse in addition to cannabis misuse in future treatment guidelines and research.

Entities:  

Keywords:  alcohol; cannabis; clinical measures; early psychosis; social and occupational functioning; substance use disorder

Year:  2020        PMID: 32013556      PMCID: PMC7265604          DOI: 10.1177/0706743720905201

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  51 in total

1.  Substance misuse in first-episode psychosis: 15-month prospective follow-up study.

Authors:  D Wade; S Harrigan; J Edwards; P M Burgess; G Whelan; P D McGorry
Journal:  Br J Psychiatry       Date:  2006-09       Impact factor: 9.319

Review 2.  The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings.

Authors:  M G Kushner; K Abrams; C Borchardt
Journal:  Clin Psychol Rev       Date:  2000-03

Review 3.  Alcohol and depression.

Authors:  Joseph M Boden; David M Fergusson
Journal:  Addiction       Date:  2011-03-07       Impact factor: 6.526

4.  A depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; B Schissel
Journal:  Schizophr Res       Date:  1990 Jul-Aug       Impact factor: 4.939

5.  Prevalence and clinical correlates of depression in the acute phase of first episode schizophrenia.

Authors:  Eric Roche; Mary Clarke; Stephen Browne; Niall Turner; Orflaith McTuige; Moaayad Kamali; Anthony Kinsellla; Conall Larkin; John L Waddington; Eadbhard O'Callaghan
Journal:  Ir J Psychol Med       Date:  2010-03

6.  The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis.

Authors:  Leanne Hides; Sue M Cotton; Gregor Berger; John Gleeson; Colin O'Donnell; Tina Proffitt; Patrick D McGorry; Dan I Lubman
Journal:  Addict Behav       Date:  2009-03-06       Impact factor: 3.913

7.  One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?

Authors:  Elisabeth Heffermehl Lange; Ragnar Nesvåg; Petter Andreas Ringen; Cecilie Bhandari Hartberg; Unn Kristin Haukvik; Ole Andreas Andreassen; Ingrid Melle; Ingrid Agartz
Journal:  Compr Psychiatry       Date:  2013-10-19       Impact factor: 3.735

8.  Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST).

Authors:  Rachel Humeniuk; Robert Ali; Thomas F Babor; Michael Farrell; Maria L Formigoni; Jaroon Jittiwutikarn; Roseli B de Lacerda; Walter Ling; John Marsden; Maristela Monteiro; Sekai Nhiwatiwa; Hemraj Pal; Vladimir Poznyak; Sara Simon
Journal:  Addiction       Date:  2008-03-28       Impact factor: 6.526

9.  Assessing depression in schizophrenia: the Calgary Depression Scale.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Br J Psychiatry Suppl       Date:  1993-12

10.  Substance abuse in first-episode schizophrenic patients: a retrospective study.

Authors:  M C Mauri; L S Volonteri; I F De Gaspari; A Colasanti; M A Brambilla; L Cerruti
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-03-23
View more
  3 in total

1.  In Response to "Clinical Characteristics Associated with Early Phase Psychosis and Comorbid Substance Use": Methodological Concerns.

Authors:  Philippe Hwang; Lily Hechtman; Andrea Carboni-Jiménez; Ilya Demchenko; Alexandra Maduro; Noor Mady; Fama Tounkara; Ram P Sapkota; Alain Brunet
Journal:  Can J Psychiatry       Date:  2020-08-07       Impact factor: 4.356

2.  Insights About Cannabis and Psychosis Using Video Games for Young People With a First Episode of Psychosis, Particularly Those From Black Racialized Communities: Protocol for a Mixed Methods Study.

Authors:  Suzanne Archie; Lena Palaniyappan; Andrew T Olagunju; Natasha Johnson; Nicole Kozloff; Elham Sadeh; Andrea Bardell; Alexandra Baines; Kelly K Anderson; Oyedeji Ayonrinde; Manuela Ferrari
Journal:  JMIR Res Protoc       Date:  2022-05-20

Review 3.  Could Expanding and Investing in First-Episode Psychosis Services Prevent Aggressive Behaviour and Violent Crime?

Authors:  Sheilagh Hodgins
Journal:  Front Psychiatry       Date:  2022-02-15       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.